Phasing out animal testing: A new era for pharmaceutical innovation

In Europe, there is increased focus on decreasing reliance on animals, recently with the European Commission actions to develop a roadmap to phase out animals used for chemical safety testing with increasing pressure on regulators and the pharmaceutical industry to move away from using animals. Often, endeavours already made by governments, regulators, trade associations, and industry to replace, reduce and refine animal experimentation (3Rs) are unnoticed. Members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) are committed to the science-based phase-in of methods to replace the use of animals for scientific purposes and the elimination of animal tests which are obsolete or redundant.

In this webinar, Dr. Kirsty Reid will focus on providing participants with an overview of the current political and societal landscape and then dive into the actions taken at an EU level (and in some instances globally), to promote wider application and acceptance of the 3Rs. This will include focus on activities to include the 3Rs into ICH guidelines, various partnerships and projects across stakeholders to eliminate redundant tests or to streamline testing requirements or by using virtual controls. Industry is also working with stakeholders to proactively feed into the activities of the European Commission's roadmap to phase out animal testing.